CSIMarket Company Name, Ticker, Competitors, else..
 
Atara Biotherapeutics Inc   (NASDAQ: ATRA)
Other Ticker:  
 
 

Atara Biotherapeutics Inc Growth Comparisons

Select each growth Category to receive further Information



ATRA Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 1371.41 % 13.29 % 7.33 % 4 %
Q / Q Revenue Growth (Q3 MRQ) 177.89 % 9.68 % 2.74 % 0.39 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 1184.89 % 5.16 % 5.63 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 76.02 % 3.16 % 1.78 % 1.12 %
Revenue 5 Year Average Growth - 7.75 % 8.02 % 7.61 %


ATRA's Growth Comparisons in III. Quarter 2024




Reporting 1371.41% surge year on year in the third quarter 2024 Revenue, Atara Biotherapeutics Inc led the 13.29% rise in the Biotechnology & Pharmaceuticals industry, and 7.33% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Biotechnology & Pharmaceuticals industry, helped to elevate overall market growth to 4%.

Company's sequential Revenue growth rate was impressive 177.89% from the second quarter. Average yearly sales growth for Atara Biotherapeutics Inc is %, while S & P 500's average annual sales growth is 7.61% over the five years, including only Businesses with the third quarter 2024 financial reports.

ATRA Growth Rates by Company's Segments

Segment Name
Y / Y
Seq.
Total
1371.41 %
177.89 %


Growth Rates of ATRA's Income in the third quarter 2024


ATRA Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - 254.56 % 79.67 % 4.45 %
Seq. Operating Income Change (Q3 MRQ) - -27.11 % 32.65 % -2.32 %
Y / Y Operating Income Growth (Q3 TTM) - -91 % -6.23 % 9.3 %
Seq. Operating Income Growth (Q3 TTM) - - 19.49 % 1.41 %
Operating Income 5 Year Avg. Change - - 6.12 % 9.13 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) - - 297.79 % -1.43 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - 339.77 % 118.23 % -8.76 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - - 24.99 % 8.89 %
Seq. Income from Cont. Ops. Change (Q3 TTM) - - 55.93 % -0.02 %
Income from Cont. Ops. 5 Year Avg. Change - - -9.72 % 7.31 %

ATRA Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) - - 7.75 % -6.22 %
Q / Q Net Income Growth (Q3 MRQ) - 339.67 % 131.96 % -6.76 %
Y / Y Net Income Change (Q3 TTM) - - -11.95 % 5.26 %
Seq. Net Income Change (Q3 TTM) - - 1.81 % -1.37 %
Net Income 5 Year Avg. Growth - - -3.38 % 7.45 %

ATRA's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - - 297.79 % -1.43 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - 336.85 % 118.23 % -8.76 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) - - - -6.57 %
EPS from Cont. Ops. 5 Year Avg. Growth - - -9.72 % 7.31 %



ATRA EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - - 7.75 % -6.22 %
Q / Q EPS Net Growth (Q3 MRQ) - 336.74 % 131.96 % -6.76 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 44.84 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) - - - -6.16 %
EPS Net 5 Year Avg. Change - - -3.38 % 7.45 %



Atara Biotherapeutics Inc reported bottom-line of $ -2.93 in the third quarter, compare to $ -16.50 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry grew by 13.29%, while Healthcare sector increased by 7.75%, and overall market declined by -6.22%.

The Company's sequential EPS growth rate was very impressive 177.89% from the second quarter. Average yearly income per share growth for Atara Biotherapeutics Inc is %, while S & P 500's average annual income per share growth is 7.45% over the five years, including only Businesses with the third quarter 2024 earnings results.

ATRA Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - 163.4 % 38.09 % -42.75 %
Seq. Free Cash Flow Change (Q3 MRQ) - 143.85 % 108.45 % -36.75 %
Y / Y Free Cash Flow Change (Q3 TTM) - -0.49 % 4.69 % 3.44 %
Seq. Free Cash Flow Change (Q3 TTM) - 32.46 % 8.11 % -10.82 %
Free Cash Flow 5 Year Avg. Change - -28.23 % 7 % 11.94 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) -19.87 % - -74.08 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 4.41 % 11.17 % -33.53 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) - 3.93 % 1.43 % 2.78 %
Seq. Capital Expenditures Change (Q3 MRQ) - 5.66 % 5.75 % 2.91 %
Y / Y Capital Expenditures Change (Q3 TTM) -83.55 % 5.33 % 3.08 % 70.28 %
Seq. Capital Expenditures Change (Q3 TTM) -58.42 % 0.4 % 2.03 % -0.52 %
Capital Expenditures 5 Year Avg. Change - -1.88 % 9.35 % 8.99 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com